• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MAP 0.00% 18.0¢

MICROBA LIFE SCIENCES LIMITED

Healthcare

Microba Life Sciences Limited is an Australia-based precision microbiome company. The... Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for major chronic diseases and delivers gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Through its analysis and discovery platforms, it identifies microbiome-derived therapeutics and diagnostic tools to advance medicine. Through its Analysis Platform, it generates a global databank of microbiome samples and associated metadata to develop new health solutions. Its Discovery Platform enables partners to access this databank for the data-driven discovery of product opportunities. Its therapeutic platform is a repeatable platform for microbial therapeutic leads. It also offers a product portfolio of gastrointestinal, vaginal, oral, and urinary microbiome testing, together with a targeted set of evidence-based formulations. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MAP
News: MAP Microba Life Sciences Posts H1 Revenue Result Of A$3.27M
28/02/24 0 99
28/02/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  99 
MAP 28/02/24 0 115
28/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  115 
MAP 26/02/24 0 150
26/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  150 
MAP 16/02/24 7 3.0K
16/02/24 Last post  seahunt Comments Created with Sketch.  7  Views Created with Sketch.  3.0K 
MAP
News: MAP Microba Life Sciences Says 1H Unaudited Revenue Totalled A$3.27M
30/01/24 0 221
30/01/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  221 
MAP 30/01/24 0 215
30/01/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  215 
MAP 29/01/24 0 167
29/01/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  167 
MAP 25/01/24 0 152
25/01/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  152 

See All Discussions arrow Created with Sketch.

Timeline

Appendix 4D & FY24 Interim Report
28 Feb 09:02
 
Change in substantial holding
26 Feb 16:47
 
Q2 FY24 Quarterly Investor Presentation
30 Jan 09:23
 
Q2 FY24 Quarterly Activities Report & Appendix 4C
30 Jan 09:11
 
Details of Q2 FY24 Quarterly Report, Appendix 4C & Webinar
29 Jan 09:09
 
Notification of cessation of securities - MAP
25 Jan 17:14
 
View More arrow Created with Sketch.
(20min delay)
Last
18.0¢
Change
0.000(0.00%)
Mkt cap ! $71.96M
Open High Low Value Volume
18.5¢ 18.5¢ 17.5¢ $55.60K 314.0K

Buyers (Bids)

No. Vol. Price($)
2 162500 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 221250 2
View Market Depth
Last trade - 16.10pm 01/03/2024 (20 minute delay) ?
Last
18.0¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
18.5¢ 18.5¢ 17.5¢ 146890
Last updated 14.55pm 01/03/2024 ?
MAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.